Table 5 The EuroClonality uniform system for molecular conclusion

From: EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations

Overall technical description for all Ig or TCR targets

Molecular interpretation/conclusion

Optional: more detailed molecular interpretation a

No (specific) product, poor DNA quality

Not evaluable, due to poor DNA quality

 

No (specific) product

No rearrangement in Ig/TCR targets detected

 

Clonal (… nt)f

Clonality detected

Clonality detected (biallelic products)

Clonality detected (biclonality)

Clonality detected (minor clonal product)

Clonality detected (isolated rearrangement) clonality detected (with caution, plus advice for follow-up analysis/new sample)

Clonality detected in addition to background of B/T cells

Pseudoclonal (one or more non-reproducible products)

No clonality detected, suggestive of low template amount

 

Multiple reproducible products (n3)b

Oligoclonality/multiple clones detected

Dominant clone in oligo/polyclonal background

Polyclonal (not clonalc)

Polyclonality detected (no clonality detectedc)

Polyclonality detected plus minor clone of unknown significanced

Not evaluable

Not evaluablee

 
  1. Abbreviations: HD, heteroduplex; Ig, immunoglobulin; IGK, IG kappa; nt, nucleotide; TCR, T-cell receptor; TCRB, TCR beta.
  2. aExamples of more detailed molecular interpretation options that can be chosen by the user.
  3. bFor IGK and TCRB loci up to four clonal products may be compatible with one clone.
  4. cIn HD analysis a polyclonal smear may not always be clearly detectable, despite specific product in agarose gel; hence this is scored as ‘not clonal’.
  5. dFor those cases in which minor reproducible peaks/bands are detected in the polyclonal background.
  6. eIn <5% of cases the molecular interpretation cannot be made.
  7. fClonal peaks/bands are not necessarily seen for every Ig/TCR target analyzed to reach the molecular conclusion ‘clonality detected’.